Targeting Transcription Factor Activity as a Strategy to Inhibit Pro- Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|35|4392-4404

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.35, 2010-12, pp. : 4392-4404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria

By  

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 15-28

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a Therapeutic Target for Transcription Factor Decoy Strategy in Inflammatory Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 51-56

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases

By  

Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. : 339-346

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting ENaC as a Molecular Suspect in Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 951-957

Bentham Science Publishers

Access to resources Recommend Favorite

Transcriptional modulation of hepatocyte nuclear factor 4a (HNF-4a) and/or peroxisome proliferator-activated receptor a (PPARa)-controlled genes by low molecular weight compounds

By Bar-Tana J.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 141-144

Informa Healthcare

Access to resources Recommend Favorite